Even though these cancer immunotherapy approaches have been recently shadowed by the tremendous success of immune checkpoint inhibitors (ICI), IL-2 therapy is still being used to treat certain cancers such as renal cell carcinoma [12]. This evidence concerns the gene IL2 and cancer.